AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteMK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.
More Information Supplier PageMK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.
More Information Supplier PageMK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information Supplier PageMK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information Supplier PageMK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information Supplier PageMK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information Supplier PageMK591 is selective and specific inhibitor of 5-Lipoxygenase-activating protein (FLAP).
More Information Supplier PageMK591 is selective and specific inhibitor of 5-Lipoxygenase-activating protein (FLAP).
More Information Supplier PageMK591 is selective and specific inhibitor of 5-Lipoxygenase-activating protein (FLAP).
More Information Supplier PageOccupies mortalin-2 (mot-2), a member of the Hsp70 family, at its p53 binding site and enables p53 translocation to the nucleus. Selectively cytotoxic; causes growth arrest of cancer cells in culture. Also inhibits telomerase activity and cross-links F-actin.
More Information Supplier PageOccupies mortalin-2 (mot-2), a member of the Hsp70 family, at its p53 binding site and enables p53 translocation to the nucleus. Selectively cytotoxic; causes growth arrest of cancer cells in culture. Also inhibits telomerase activity and cross-links F-actin.
More Information Supplier PageOccupies mortalin-2 (mot-2), a member of the Hsp70 family, at its p53 binding site and enables p53 translocation to the nucleus. Selectively cytotoxic; causes growth arrest of cancer cells in culture. Also inhibits telomerase activity and cross-links F-actin.
More Information Supplier PageOccupies mortalin-2 (mot-2), a member of the Hsp70 family, at its p53 binding site and enables p53 translocation to the nucleus. Selectively cytotoxic; causes growth arrest of cancer cells in culture. Also inhibits telomerase activity and cross-links F-actin.
More Information Supplier PageML-161 is an inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 ??M for the inhibition of platelet P-selectin expression on human platelets).
More Information Supplier PageML-161 is an inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 ??M for the inhibition of platelet P-selectin expression on human platelets).
More Information Supplier PageML-161 is an inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 ??M for the inhibition of platelet P-selectin expression on human platelets).
More Information Supplier PageML-161 is an inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 ??M for the inhibition of platelet P-selectin expression on human platelets).
More Information Supplier PageML-161 is an inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 ??M for the inhibition of platelet P-selectin expression on human platelets).
More Information Supplier PageML-228 is an activator of the HIF signaling pathway, as demonstrated by HIF response element (HRE) reporter assay, HIF-1?? nuclear translocation assay, and increased VEGF expression.
More Information Supplier PageML-228 is an activator of the HIF signaling pathway, as demonstrated by HIF response element (HRE) reporter assay, HIF-1?? nuclear translocation assay, and increased VEGF expression.
More Information Supplier PageML-228 is an activator of the HIF signaling pathway, as demonstrated by HIF response element (HRE) reporter assay, HIF-1?? nuclear translocation assay, and increased VEGF expression.
More Information Supplier PageML 7 hydrochloride is a selective inhibitor of myosin light chain kinase (MLCK).
More Information Supplier PageML 7 hydrochloride is a selective inhibitor of myosin light chain kinase (MLCK).
More Information Supplier PageML 7 hydrochloride is a selective inhibitor of myosin light chain kinase (MLCK).
More Information Supplier PageML 7 hydrochloride is a selective inhibitor of myosin light chain kinase (MLCK).
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageML323 is a selective and highly potent USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
More Information Supplier PageML323 is a selective and highly potent USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
More Information Supplier PageML323 is a selective and highly potent USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
More Information Supplier PageML323 is a selective and highly potent USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
More Information Supplier PageML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier PageML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier PageML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier PageML-314 is a brain penetrant nonpeptidic ??-arrestin biased ggonist of the neurotensin NTR1 receptor, which exhibits full agonist behavior against NTR1 (EC50 = 2.0 ??M) in the primary assay and selectivity against NTR2.
More Information Supplier PageML-314 is a brain penetrant nonpeptidic ??-arrestin biased ggonist of the neurotensin NTR1 receptor, which exhibits full agonist behavior against NTR1 (EC50 = 2.0 ??M) in the primary assay and selectivity against NTR2.
More Information Supplier Page
